GNH USA

Europe — EMA

Panzyga (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a 10% solution for intravenous use. It treats primary immunodeficiency diseases and provides immune support in patients…

Request sourcing

1
Pack/s

What is Human Normal Immunoglobulin?

Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a 10% solution for intravenous use. It treats primary immunodeficiency diseases and provides immune support in patients with antibody deficiencies. GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Human Normal Immunoglobulin used for?

Panzyga is an immunoglobulin used to replace missing or deficient antibodies in primary immunodeficiency disorders. It helps : - Primary Immunodeficiency Disease (PID): Provides the necessary antibody coverage to reduce infection risk. - Secondary Immunodeficiency after bone marrow transplant (BMT): Offers protect protect protect protect protect . -    -  . -  . -  -  -  -  -  -  -  -  -  -  -  -  -  -  - 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Normal Immunoglobulin
Route
Intravenous Use
Manufacturer
Octapharma Produtos Farmaceuticos, Lda.
Origin
EU

Related products